CDS Analytical Secures Exclusive License for Cutting-Edge Proteomics Technology from University of Delaware
OXFORD, PA — CDS Analytical LLC has secured an exclusive licensing agreement with the University of Delaware to commercialize an innovative proteomics sample preparation technology, known as E3technology. Developed by UD researcher Dr. Yanbao Yu, this groundbreaking technology simplifies and standardizes proteomics analysis across a wide range of biological samples.
E3technology builds on the robust Empore™ membrane technology, making it more reliable and user-friendly. This advancement will expand CDS Analytical’s current Empore product line with new offerings including E3tip, E3filter, E3cartridge, and E3plate. These products aim to provide comprehensive coverage of proteome sample preparation, thereby enhancing efficiency and accuracy.
Dr. Yu, Director of Proteomics at UD, highlighted the significant advantages of E3technology. “In our recent study, E3technology showed superior performance in the context of proteome-wide analysis of various sample types,” he said. The enhanced single-vessel approach bypasses cell lysis, streamlining intact cell proteome analysis and increasing sensitivity. “It can be quite a game-changer for low-cell or single-cell proteomics*,” Yu added.
“We are very excited to exclusively license the commercial rights to this innovative technology to CDS Analytical," Dr. Yu stated, emphasizing the commercial potential and broad applicability of this technology for the proteomics community.
Guotao Lu, Empore Division Manager at CDS Analytical, expressed enthusiasm about the agreement. “We are glad to have this opportunity to commercialize this revolutionary technology from the University of Delaware,” he said. Combining E3technology with CDS Analytical’s StageTips technology and the MiniLab 5000 liquid handler, the company aims to build a one-stop solution for proteomics sample preparation from cells to LC-MS. “Our goal is to help improve efficiency and save costs for proteomics fields, enabling scientists to explore and understand biological systems more effectively,” Lu added.
This partnership between CDS Analytical and the University of Delaware promises to accelerate scientific breakthroughs in human biology, addressing unmet medical needs, and advancing the field of proteomics.
For more information, visit CDS Analytical or University of Delaware.
Note: The information contained within this article is based on a recent press release and representative of its accuracy at that time.
